Tatiana V. Petrova*
Division of Experimental Oncology, Multidisciplinary Oncology Center, University of Lausanne and CHUV, Switzerland
ABSTRACT Kari Alitalo is one of the leaders in the field of lymphangiogenesis. Research from his laboratory has contributed to the transformation of a largely descriptive field into a dynamic discpline, which now holds promise for the treatment of cancer, inflammation and vascular dysfunction. The interview intends to provide historical insights into these changes and hopefully inspiration to the young generation of vascular biologists.
Keywords:*Corresponding author e-mail: tatiana.petrova@unil.ch